|
Real-time Estimate
Tradegate
01:07:19 22/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 58.78 EUR | -0.13% |
|
+1.73% | -7.32% |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 74.36 | +26.35% | 9 | ||||||
| 1,325.39 | +13.78% | 29 | ||||||
| 277.91 | +3.13% | 22 | ||||||
| 278.61 | +5.34% | 28 | ||||||
| 375.34 | +2.89% | 19 | ||||||
| 152.66 | +7.94% | 22 | ||||||
| 211.28 | +25.8% | 23 | ||||||
| 387.69 | -1.39% | 29 | ||||||
| 308.86 | +18.79% | 23 | ||||||
| 158.15 | +5.04% | 27 | ||||||
| 28.88 | +4.09% | 26 | ||||||
| 570.07 | +11.62% | 28 | ||||||
| 66.71 | +6.53% | 24 | ||||||
| 94.06 | +26.1% | 24 | ||||||
| 21.71 | +13.61% | 21 | ||||||
| 9,323.33 | +38.21% | 15 | ||||||
| 6,622.06 | +10.96% | 16 | ||||||
| 58.22 | +18.75% | 18 | ||||||
| 71.35 | +54.98% | 17 | ||||||
| Average | 1,074.03 | +15.40% | 22 | ||||||
| Weighted average by Cap. | 726.07 | +10.45% | 25 |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
